HEADER PROTEIN BINDING 24-AUG-21 7V9B TITLE CRYSTAL STRUCTURE OF 14-3-3 EPSILON WITH FOXO3A PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: YWHAE/FAM22B FUSION PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ARG-ARG-ARG-ALA-VAL-SEP-MET-ASP-ASN-SER-ASN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: TAMRA LABELED PEPTIDE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAE/FAM22B FUSION; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS FOXO3A, 14-3-3, 14-3-3 EPSILON, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR S.MATHIVANAN,N.KAMARIAH REVDAT 3 29-NOV-23 7V9B 1 REMARK REVDAT 2 07-SEP-22 7V9B 1 REMARK REVDAT 1 31-AUG-22 7V9B 0 JRNL AUTH S.MATHIVANAN,P.K.CHUNCHAGATTA LAKSHMAN,M.SINGH,S.GIRIDHARAN, JRNL AUTH 2 K.SATHISH,M.A.HURAKADLI,K.BHARATHAM,N.KAMARIAH JRNL TITL STRUCTURE OF A 14-3-3 EPSILON :FOXO3A PS253 PHOSPHOPEPTIDE JRNL TITL 2 COMPLEX REVEALS 14-3-3 ISOFORM-SPECIFIC BINDING OF FORKHEAD JRNL TITL 3 BOX CLASS O TRANSCRIPTION FACTOR (FOXO) PHOSPHOPROTEINS. JRNL REF ACS OMEGA V. 7 24344 2022 JRNL REFN ESSN 2470-1343 JRNL PMID 35874228 JRNL DOI 10.1021/ACSOMEGA.2C01700 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0257 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 21400 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.189 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1149 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1532 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE SET COUNT : 84 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1926 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.09 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.56000 REMARK 3 B22 (A**2) : -0.57000 REMARK 3 B33 (A**2) : 2.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.129 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.113 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.787 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2016 ; 0.013 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 1907 ; 0.002 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2716 ; 1.750 ; 1.645 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4407 ; 1.541 ; 1.599 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 239 ; 5.303 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 113 ;33.087 ;22.035 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 373 ;13.625 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;18.549 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 257 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2351 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 424 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 956 ; 2.138 ; 2.200 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 955 ; 2.129 ; 2.198 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1192 ; 2.982 ; 3.281 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1193 ; 2.983 ; 3.283 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1060 ; 3.662 ; 2.716 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1061 ; 3.661 ; 2.720 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1524 ; 5.541 ; 3.899 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2354 ; 7.014 ;27.522 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2355 ; 7.013 ;27.545 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7V9B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1300024306. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : RRCAT INDUS-2 REMARK 200 BEAMLINE : PX-BL21 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97947 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22570 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 36.460 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : 0.12000 REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.74300 REMARK 200 R SYM FOR SHELL (I) : 0.74300 REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2BR9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE PH 8.0, 10 % PEG 4000, REMARK 280 30 % MPD, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.64000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.64000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.94000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.52000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.94000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.52000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.64000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.94000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 40.52000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 41.64000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.94000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 40.52000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 311.52000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 41.64000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 453 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -16 REMARK 465 SER A -15 REMARK 465 HIS A -14 REMARK 465 MET A -13 REMARK 465 ALA A -12 REMARK 465 SER A -11 REMARK 465 MET A -10 REMARK 465 THR A -9 REMARK 465 GLY A -8 REMARK 465 GLY A -7 REMARK 465 GLN A -6 REMARK 465 GLN A -5 REMARK 465 MET A -4 REMARK 465 GLY A -3 REMARK 465 ARG A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 ASN B 256 REMARK 465 SER B 257 REMARK 465 ASN B 258 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 19 78.81 -110.04 REMARK 500 HIS A 107 -63.71 -125.40 REMARK 500 REMARK 500 REMARK: NULL DBREF 7V9B A 1 232 UNP G9K389 G9K389_HUMAN 11 242 DBREF 7V9B B 248 258 PDB 7V9B 7V9B 248 258 SEQADV 7V9B GLY A -16 UNP G9K389 EXPRESSION TAG SEQADV 7V9B SER A -15 UNP G9K389 EXPRESSION TAG SEQADV 7V9B HIS A -14 UNP G9K389 EXPRESSION TAG SEQADV 7V9B MET A -13 UNP G9K389 EXPRESSION TAG SEQADV 7V9B ALA A -12 UNP G9K389 EXPRESSION TAG SEQADV 7V9B SER A -11 UNP G9K389 EXPRESSION TAG SEQADV 7V9B MET A -10 UNP G9K389 EXPRESSION TAG SEQADV 7V9B THR A -9 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLY A -8 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLY A -7 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLN A -6 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLN A -5 UNP G9K389 EXPRESSION TAG SEQADV 7V9B MET A -4 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLY A -3 UNP G9K389 EXPRESSION TAG SEQADV 7V9B ARG A -2 UNP G9K389 EXPRESSION TAG SEQADV 7V9B GLY A -1 UNP G9K389 EXPRESSION TAG SEQADV 7V9B SER A 0 UNP G9K389 EXPRESSION TAG SEQRES 1 A 249 GLY SER HIS MET ALA SER MET THR GLY GLY GLN GLN MET SEQRES 2 A 249 GLY ARG GLY SER MET ASP ASP ARG GLU ASP LEU VAL TYR SEQRES 3 A 249 GLN ALA LYS LEU ALA GLU GLN ALA GLU ARG TYR ASP GLU SEQRES 4 A 249 MET VAL GLU SER MET LYS LYS VAL ALA GLY MET ASP VAL SEQRES 5 A 249 GLU LEU THR VAL GLU GLU ARG ASN LEU LEU SER VAL ALA SEQRES 6 A 249 TYR LYS ASN VAL ILE GLY ALA ARG ARG ALA SER TRP ARG SEQRES 7 A 249 ILE ILE SER SER ILE GLU GLN LYS GLU GLU ASN LYS GLY SEQRES 8 A 249 GLY GLU ASP LYS LEU LYS MET ILE ARG GLU TYR ARG GLN SEQRES 9 A 249 MET VAL GLU THR GLU LEU LYS LEU ILE CYS CYS ASP ILE SEQRES 10 A 249 LEU ASP VAL LEU ASP LYS HIS LEU ILE PRO ALA ALA ASN SEQRES 11 A 249 THR GLY GLU SER LYS VAL PHE TYR TYR LYS MET LYS GLY SEQRES 12 A 249 ASP TYR HIS ARG TYR LEU ALA GLU PHE ALA THR GLY ASN SEQRES 13 A 249 ASP ARG LYS GLU ALA ALA GLU ASN SER LEU VAL ALA TYR SEQRES 14 A 249 LYS ALA ALA SER ASP ILE ALA MET THR GLU LEU PRO PRO SEQRES 15 A 249 THR HIS PRO ILE ARG LEU GLY LEU ALA LEU ASN PHE SER SEQRES 16 A 249 VAL PHE TYR TYR GLU ILE LEU ASN SER PRO ASP ARG ALA SEQRES 17 A 249 CYS ARG LEU ALA LYS ALA ALA PHE ASP ASP ALA ILE ALA SEQRES 18 A 249 GLU LEU ASP THR LEU SER GLU GLU SER TYR LYS ASP SER SEQRES 19 A 249 THR LEU ILE MET GLN LEU LEU ARG ASP ASN LEU THR LEU SEQRES 20 A 249 TRP THR SEQRES 1 B 11 ARG ARG ARG ALA VAL SEP MET ASP ASN SER ASN HET SEP B 253 10 HET GOL A 301 6 HET GOL A 302 6 HET MPD A 303 8 HET IMD A 304 5 HET 323 B 301 31 HETNAM SEP PHOSPHOSERINE HETNAM GOL GLYCEROL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM IMD IMIDAZOLE HETNAM 323 2-[3,6-BIS(DIMETHYLAMINO)XANTHEN-9-YL]-5-METHANOYL- HETNAM 2 323 BENZOATE HETSYN SEP PHOSPHONOSERINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN 323 5-CARBOXY-N,N'-TETRAMETHYL RHODAMINE FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 MPD C6 H14 O2 FORMUL 6 IMD C3 H5 N2 1+ FORMUL 7 323 C25 H22 N2 O4 FORMUL 8 HOH *161(H2 O) HELIX 1 AA1 ASP A 2 GLU A 18 1 17 HELIX 2 AA2 ARG A 19 GLY A 32 1 14 HELIX 3 AA3 THR A 38 GLY A 74 1 37 HELIX 4 AA4 GLY A 75 HIS A 107 1 33 HELIX 5 AA5 HIS A 107 ALA A 112 1 6 HELIX 6 AA6 THR A 114 PHE A 135 1 22 HELIX 7 AA7 THR A 137 LEU A 163 1 27 HELIX 8 AA8 HIS A 167 ILE A 184 1 18 HELIX 9 AA9 SER A 187 GLU A 205 1 19 HELIX 10 AB1 LEU A 206 LEU A 209 5 4 HELIX 11 AB2 SER A 213 THR A 232 1 20 LINK N ARG B 248 C25 323 B 301 1555 1555 1.42 LINK C VAL B 252 N SEP B 253 1555 1555 1.33 LINK C SEP B 253 N MET B 254 1555 1555 1.32 CRYST1 77.880 81.040 83.280 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012840 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012008 0.00000